Circulating autoantibodies to troponin I in Emery-Dreifuss muscular dystrophy

Acta Myologica

Volumn 27, Issue JULY, 2008, Pages 1-6

  Niebroj Dobosz, I ^a   Marchel, M ^b   Madej, A ^a   Sokolowska, B ^a   Hausmanowa Petrusewicz, I ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cardiac autoantibodies; Dilated cardiomyopathy; Emery Dreifuss muscular dystrophy

Indexed keywords

AUTOANTIBODY; TROPONIN I ANTIBODY;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; AUTOSOMAL DOMINANT DISORDER; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; EMERY DREIFUSS MUSCULAR DYSTROPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; IMMUNOPATHOGENESIS; MALE; NON INVASIVE MEASUREMENT; PREDICTION; RISK FACTOR; X CHROMOSOME LINKED DISORDER;

AUTOANTIBODIES; CARDIOMYOPATHY, DILATED; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUSCULAR DYSTROPHY, EMERY-DREIFUSS; TROPONIN I;

EID: 51649113234     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Petrich GB, Gong XC, Lerner DL, et al. c-JUN N terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes. Circ Res 2002;91:640-7.
2. Petrich GB, Molkentin JD, Wang Y. Temporal activation of c-JUNn N-terminal kinase in adult transgenic heart via cre-loxP-mediated DNA recombination. FASEB J 2003;17:749-51.
3. Muchir A, Pavlidis P, Decostre V, et al. Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. J Clin Invest 2007;117:1282-93.
4. Muchir A, Pavlidis P, Bonne G, et al. Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery-Dreifuss muscular dystrophy. Hum Mol Genet 2007;16:1884-95
5. Caforio AL, Bonifacio E, Stewart JT, et al. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 1990;15:1527-34.
6. Caforio AL, Grazzini M, Mann JM, et al. Identification of α- and β-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992;85:1734-42.
7. Caforio AL, Goldman JH, Haven AJ, et al. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives. Internat J Cardiol 1996;54:157-63.
8. Lauer B, Padberg K, Schultheiss HP, Stauer BE. Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy (in German). Zeitschr Kard 1995;84:301-10.
9. Goldman JH, Keeling PJ, Warraich RS, et al. Autoimmunity to α-myosin in a subset of patients with idiopathic dilated cardiomyopathy. Brit Heart J 1995;74:598-603.
10. Latif N, Baker CS, Dunn MJ, et al. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and Western blotting. J Am Coll Cardiol 1993;22:1378-84.
11. Niebroj-Dobosz I, Dorobek M, Marchel M, Hausmanowa-Petrusewicz I. Evidence for autoimmunity to heart specific antigens in patients with Emery-Dreifuss muscular dystrophy. Acta Myol 2006;25:68-72.
12. Funakoshi M, Tsuchiya Y, Arachata K. Emerin and cardiomyopathy in Emery-Dreifuss muscular dystrophy. Neuromuscul Disord 1999;9:108-14.
13. Brodsky GL, Muntoni F, Miocic S, et al. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 2000;101:473-7.
14. Taylor MR, Fain PR, Sinagra G, et al. Familial Dilated Cardiomyopathy Registry Research Group. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol 2003;41:771-80.
15. Nikolova V, Leimens C, McMahon AC, et al. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J Clin Invest 2004;113:357-69.
16. Piercy RJ, Zhou H, Feng L, et al. Desmin immunolocalization in autosomal dominant Emery-Dreifuss muscular dystrophy. Neuromusc Disord 2007;17:297-305.
17. Caforio AL, Goldman JH, Haven AJ, et al. Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. The Myocarditis Treatment Trial Investigators. Eur Heart J 1997;18:270-5.
18. Melguizo C, Prado J, Velez C, et al. Clinical significance of antiheart antibodies after myocardial infarction. Jap Heart J 1997;38:779-86.
19. Shmilowich H, Danon A, Binah O, et al. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy. Intern J Cardiol 2007;117:198-203.
20. Lauer B, Schannwell M, Kuhl U, et al. Antimyosin autoantibodies are associated with deterioration of systolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 2000;35:11-8.
21. Caforio AL, Goldman JH, Baig MK, et al. Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Heart 1997;77:62-7.
22. de Leeuw N, Melchers WJG, Ruiter DJ, et al. Autoimmune markers are undetectable in end stage of idiopathic dilated cardiomyopathy. J Clin Pathol 1999;52:739-43.
23. Lowry PJ, Thompson RA, Littler WA. Humoral immunity in cardiomyopathy. Brit Heart J 1983;50:390-4.
24. Okazaki T, Tanaka Y, Nishio R, et al. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1 deficient mice. Nat Med 2003;9:1477-83.
25. Schultheiss HP, Kuhl U, Janda I, et al. Antibody mediated enhancement of calcium permeability in cardiac myocytes. J Exp Med 1988;168:2105-19.
26. Schulze K, Becker BF, Schultheiss HP. Antibodies to ADP/ATP carrier, an autoantibody in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. Circulation Res 1989;64:179-92.
27. Schulze K, Becker BF, Schauer K, Schultheiss HP. Antibodies to the ADP/ ATP carrier - an autoantigen in myocarditis and dilated cardiomyopathy - impair cardiac function. Circulation 1990;81:959-69.
28. Thorsby E, Undlien D. The HLA Associated predisposition to type 1 diabetes and other autoimmune diseases. J Pediatr Endocr Metab 1996;9:75-88.